drugset / Trial / NCT01627145

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

NCT01627145

NaSingle-groupOpen-labelTreatment

Summary

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

Timeline

Start
2012-08
Primary completion
2015-01
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg

Indications